WHAT IT IS TRYING TO CHANGE
What the project is doing
ARPA-H reverse-transcriptase ageing programme is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.
What has to happen next
The next checkpoint is a defined experiment, development partner or route into human testing.
What could stop it
The idea may never become a practical treatment, even when the biological reasoning is interesting.